Dicerna Pharmaceuticals competitors

Zippia score 4.6

Dicerna Pharmaceuticals main competitors are Rigel Pharmaceuticals, Alnylam Pharmaceuticals, and Jounce Therapeutics.

Competitor Summary. See how Dicerna Pharmaceuticals compares to its main competitors:

Alnylam Pharmaceuticals has the most employees (1,323).
Employees at Rigel Pharmaceuticals earn more than most of the competitors, with an average yearly salary of $83,403.
The oldest company is Rigel Pharmaceuticals, founded in 1996.

Work at Dicerna Pharmaceuticals?

Share your experience

Dicerna Pharmaceuticals vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Dicerna Pharmaceuticals	2007	4.6	Cambridge, MA	3	$164.3M	302
Bellicum Pharmaceuticals	2004	4.1	Houston, TX	1	$1.5M	16
Alnylam Pharmaceuticals	2002	4.8	Cambridge, MA	2	$2.2B	1,323
Jounce Therapeutics	2013	4.4	Cambridge, MA	1	$82.0M	137
Aprecia Pharmaceuticals	2004	4.3	Langhorne, PA	3	$16.4M	20
Rigel Pharmaceuticals	1996	4.2	South San Francisco, CA	2	$179.3M	158
GenMark Diagnostics	2010	4.3	Carlsbad, CA	8	$171.6M	618

Rate how well Dicerna Pharmaceuticals differentiates itself from its competitors.

Dicerna Pharmaceuticals salaries vs competitors

Among Dicerna Pharmaceuticals competitors, employees at Rigel Pharmaceuticals earn the most with an average yearly salary of $83,403.

Compare Dicerna Pharmaceuticals salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Dicerna Pharmaceuticals	$84,090	$40.43	-
Bellicum Pharmaceuticals	$65,106	$31.30	-
Alnylam Pharmaceuticals	$81,014	$38.95	-
Jounce Therapeutics	$79,158	$38.06	-
Aprecia Pharmaceuticals	$45,659	$21.95	-
Rigel Pharmaceuticals	$83,403	$40.10	-

Compare Dicerna Pharmaceuticals job title salaries vs competitors

Company	Highest salary	Hourly salary
Dicerna Pharmaceuticals	$42,276	$20.32
Jounce Therapeutics	$45,052	$21.66
Rigel Pharmaceuticals	$44,470	$21.38
Alnylam Pharmaceuticals	$37,481	$18.02
Bellicum Pharmaceuticals	$35,551	$17.09
Aprecia Pharmaceuticals	$35,513	$17.07
GenMark Diagnostics	$35,372	$17.01

Do you work at Dicerna Pharmaceuticals?

Does Dicerna Pharmaceuticals effectively differentiate itself from competitors?

Dicerna Pharmaceuticals jobs

Dicerna Pharmaceuticals demographics vs competitors

Compare gender at Dicerna Pharmaceuticals vs competitors

Job title	Male	Female
GenMark Diagnostics	43%	57%
Alnylam Pharmaceuticals	49%	51%
Rigel Pharmaceuticals	72%	28%
Aprecia Pharmaceuticals	83%	17%
Dicerna Pharmaceuticals	-	-

Male

Female

100%

75%

50%

25%

Dicerna Pharmaceuticals

Aprecia Pharmaceuticals

Rigel Pharmaceuticals

Alnylam Pharmaceuticals

GenMark Diagnostics

25%

50%

75%

100%

Compare race at Dicerna Pharmaceuticals vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Alnylam Pharmaceuticals	59%	14%	5%	16%	6%	9.1
GenMark Diagnostics	42%	31%	7%	12%	8%	8.8
Rigel Pharmaceuticals	36%	28%	5%	25%	5%	7.4
Aprecia Pharmaceuticals	51%	11%	8%	25%	5%	7.5

Dicerna Pharmaceuticals revenue vs competitors

Dicerna Pharmaceuticals revenue is $164.3M. Among it's competitors, the company with the highest revenue is Alnylam Pharmaceuticals, $2.2B . The company with the lowest revenue is Bellicum Pharmaceuticals, $1.5M.

Dicerna Pharmaceuticals and similar companies CEOs

CEOBio

Yvonne L. Greenstreet

Alnylam Pharmaceuticals

Yvonne Greenstreet is a COO at ALNYLAM PHARMACEUTICALS, INC..

Hany Massarany

GenMark Diagnostics

Hany Massarany is a President & CEO at GENMARK DIAGNOSTICS, INC. and is based in Carlsbad, California.

Richard Murray (Rich)

Jounce Therapeutics

Rich has over 20 years of R&D experience involving the immune system and cancer. He has established and operated protein therapeutic efforts in start-up as well as large pharmaceutical companies.

Mr. George B. Kauffman

Rigel Pharmaceuticals

Mr. George B. Kauffman is a Chairman Chief Executive Officer;Chief Investment Officier at RIGEL PHARMACEUTICALS INC and is based in United States.

Christopher E. Gilmore

Aprecia Pharmaceuticals

Mr. Gilmore was named Aprecia’s Chief Executive Officer in April 2019. He previously served as Vice President, Strategic Business Ventures at Prasco Laboratories, where he made significant contributions to corporate growth. His more than 22 years of experience include leadership awards in sales, marketing, business strategy, M&A and global commercialization. During his time at Prasco, Gilmore served as a business development consultant for Aprecia, where he successfully established key business partnerships.

Dicerna Pharmaceuticals competitors FAQs

What is Dicerna Pharmaceuticals's biggest competitor?

Have more questions? See all answers to common company questions.

Search for jobs

Companies
Massachusetts
Cambridge, MA
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals Competitors

Updated December 16, 2025